- 全部删除
- 您的购物车当前为空
Dehydro aripiprazole is the primary, active metabolite of aripiprazole, an atypical antipsychotic. The metabolite is produced from the parent compound by the actions of cytochrome P450 (CYP) isoforms CYP3A4 and CYP2D6. Dehydro aripiprazole has similar pharmacological properties to aripiprazole.
Dehydro aripiprazole is the primary, active metabolite of aripiprazole, an atypical antipsychotic. The metabolite is produced from the parent compound by the actions of cytochrome P450 (CYP) isoforms CYP3A4 and CYP2D6. Dehydro aripiprazole has similar pharmacological properties to aripiprazole.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | 待估 | 35日内发货 | |
5 mg | 待估 | 35日内发货 | |
10 mg | 待估 | 35日内发货 |
Dehydro Aripiprazole (hydrochloride) 相关产品
产品描述 | Dehydro aripiprazole is the primary, active metabolite of aripiprazole, an atypical antipsychotic. The metabolite is produced from the parent compound by the actions of cytochrome P450 (CYP) isoforms CYP3A4 and CYP2D6. Dehydro aripiprazole has similar pharmacological properties to aripiprazole. |
靶点活性 | 5-HT 1A Receptor:4.2 nM (Ki) |
分子量 | 482.83 |
分子式 | C23H26Cl3N3O2 |
CAS No. | 1008531-60-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
溶解度信息 | DMF: 25 mg/mL (51.78 mM), Sonication is recommended. DMF:PBS (pH 7.2)(1:3): 0.25 mg/mL (0.52 mM), Sonication is recommended. DMSO: 20 mg/mL (41.42 mM), Sonication is recommended. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容